Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study - Zhao, Dong; Bi, Minghong; Cheng, Xiaofei; Wang, Shuhong; Cheng, Huaidong; Xia, Xiaoyang; Chen, Huan; Zhang, Yanbei; Hu, Zhiqiang; Cao, Qisheng; Liang, Hui; Wang, Fan; et al. (Frontiers in Immunology, 2025)